BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 23.95
-0.80 (-3.23%)
At close: Apr 17, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.19 billion as of April 17, 2026. Its market cap has decreased by -16.27% in one year.
Market Cap
3.19B
Enterprise Value
2.15B
Revenue
5.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.95
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.19B, an increase of 80.66%. That is a compound annual growth rate of 16.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.19B | -19.50% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.87B |
| Genovate Biotechnology | 3.71B |
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.16B |
| Apex Biotechnology | 2.96B |
| Intech Biopharm | 2.93B |
| Syngen Biotech | 2.89B |
| HeXun Biosciences | 2.80B |